Cell & Bioscience · 2014 · 38 citations · 28 references
MedicineOncologyPathologyHepatologyHistopathologyMolecular PathologyHepatic PathologyHepatobiliary CancerHepatobiliary PathologyHepatocellular CarcinomaLiver CancerLiver DiseaseClinicopathological CorrelationHepatic Progenitor Cell BiologyHepatic Progenitor CellsLiver Disease PrognosisLiver Progenitor CellsPrognostic BiomarkersProliferative IndexTissue Microarray Analysis
BACKGROUND: Ductular reactions (DRs) are well documented in many acute and chronic liver disease.The DRs are thought to be the transit amplifying cells deriving from activation of the stem/progenitor cell compartments of the liver. The aim of this study was to examine the presence of proliferative index of DR (PI-DR) and HPC markers' expression in HCCs after curative hepatectomy, as well as their relationship with clinicopathological features and prognosis. RESULTS: Tissue microarray with peritumoral and intratumoral tissue samples of 120 HCCs after hepatectomy was analysed for peritumoral expression of proliferating cell nuclear antigen for PI-DR. Peritumoral and intratumoral expression status of HPC markers including EpCAM, OV6, CD133 and c-kit were also examined by immunohistochemistry. TMA analysis of HCCs revealed that peritumoral PI-DR strongly correlated with the degree of inflammation and fibrosis. The peritumoral PI-DR positively correlated with peritumoral HPC markers EpCAM, OV6, CD133 and c-kit expression. Moreover, there were highly significant correlations between peritumoral PI-DR and intratumoral HPC markers EpCAM, OV6, CD133 and c-kit expression. Further, multivariate analysis showed that peritumoral PI-DR was the independent prognostic factor for overall survival (HR; 3.316, P < 0.001), and peritumoral PI-DR had a better power to predict disease-free survival (HR; 2.618, P < 0.001). CONCLUSIONS: Peritumoral PI-DR, as a valid surrogate for peritumoral and intratumoral expression of HPC markers, could be served as a potential prognostic marker for recurrence and survival in HCC after hepatectomy.
28
Management of Hepatocellular Carcinoma *
Jordi Bruix, Morris Sherman · Hepatology · 2005 · 5.9K citations · Full text
Peter G. Isaacson, Ahmet Doǧan, Stephen K. Price et al. · The American Journal of Surgical Pathology · 1989 · 1.9K citations
Medicine, Endocrinology, Pathology +13
International Union against Cancer
Journal of the Faculty of Radiologists · 1959 · 1.2K citations